NEW YORK ─ Oxford Immunotec on Wednesday announced it has entered into an agreement for Tokyo-based Riken Genesis to exclusively distribute its T-Spot Discovery SARS-CoV-2 kit in Japan for the detection and measurement of SARS-CoV-2-specific T cells.
Financial and other details of the agreement were not disclosed.
Tokyo-based Riken Genesis, a subsidiary of Sysmex, provides products based on gene analysis for genetic testing as well as laboratory assay services.